Invesco Attracts Institutional Shifts After Mixed Third-Quarter Earnings
Invesco Ltd. reported mixed third-quarter financial results alongside dividend plans, as institutional investors made new portfolio adjustments and analysts maintained a Moderate Buy consensus.
Institutional investors have recently adjusted their holdings in Invesco Ltd. (IVZ). A regulatory filing showed Mirae Asset Global Investments Co. Ltd. established a new position in the asset manager during the third quarter, acquiring 111,068 shares valued at approximately $3,350,000. Conversely, Asset Management One Co. Ltd. reduced its stake by 77.3% during the same quarter by selling 66,617 shares, retaining 19,615 shares worth $592,000. Institutional investors and hedge funds collectively hold 66.09% of the firm's stock.
The portfolio changes follow Invesco's third-quarter earnings announcement. The company posted earnings per share of $0.72, falling short of Wall Street consensus estimates of $0.74 per share. Reports diverged regarding top-line performance: one report showed revenue grew 16.5% year over year to $1.38 billion, meeting projections, while another indicated revenue climbed 57.9% to $1.9 billion, topping estimates. Total assets under management rose 19.4% compared to the prior-year period to reach $2.5 trillion.
Alongside its quarterly results, Invesco announced a quarterly dividend of $0.2150 per share, scheduled for payment on December 2 to shareholders of record as of November 13. The annualized dividend of $0.86 provides an estimated yield of 3.0% to 3.2%. Regulatory disclosures also revealed insider sales, with Director Phoebe Wood selling 3,000 shares in September, alongside significant divestments by other company directors and executives over the same period.
Wall Street analysts hold a Moderate Buy consensus on the stock. Recent individual commentary includes UBS analyst Michael Brown maintaining a Buy rating with a $41 price target, while Morgan Stanley previously lifted its target from $31.00 to $32.00 with an equal weight rating. Overall price targets across analyst aggregations stand between $33.79 and $35.15, while GuruFocus cautioned that its proprietary GF Value metric of $18.42 indicates the stock is overvalued.